TLN-254 Clinical Trials

2 actively recruiting trials across 2 locations

Filter by location:

Palo Alto, California1 trial

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

Stanford Medicine Cancer Center

Phase 1

Stanford, California1 trial

A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma

Stanford Cancer Institute

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.